@article{JTD15034,
author = {Umberto Ricardi and Niccolò Giaj Levra and Serena Badellino and Filippo Alongi},
title = {Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {8},
year = {2017},
keywords = {},
abstract = {Oligometastatic non-small cell lung cancer (NSCLC), presenting with one to five synchronous or metachronous metastatic lesions, has recently been considered a distinct disease state (1). In this setting, three different clinical conditions can be identified: (I) de novo oligometastatic—patients with a synchronous diagnosis of primary and metastatic lesions naive from oncological treatments; (II) oligorecurrent—patients with a controlled primary tumor after loco-regional treatment but with new and limited metastatic sites; (III) oligoprogressive—patients with a limited metastatic progression during systemic therapy (one or few sites), but with a control of the primary tumor and most of metastatic disease (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/15034}
}